Progression of adult T-cell leukemia/lymphoma from smoldering to acute type due to branched subclonal evolution.
Koji Jimbo, Makoto Yamagishi, Yutaka Suzuki, Kako Suzuki, Motoko Mizukami, Kazuaki Yokoyama, Aki Sato, Tokiko Nagamura-Inoue, Yasuhito Nannya, Kaoru Uchimaru
Article in EJHaem, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors at 4 institutions in 1 country.
Koji JimboDepartment of Hematology/Oncology Research Hospital, The Institute of Medical Science, The University of Tokyo Tokyo Japan.ORCID https://orcid.org/0000-0002-2031-7385
Makoto YamagishiDepartment of Computational Biology and Medical Sciences Laboratory of Tumor Cell Biology, Graduate School of Frontier Sciences The University of Tokyo Tokyo Japan.
Yutaka SuzukiDepartment of Computational Biology and Medical Sciences Laboratory of Systems Genomics, Graduate School of Frontier Sciences The University of Tokyo Chiba Japan.
Kako SuzukiDepartment of Computational Biology and Medical Sciences Laboratory of Tumor Cell Biology, Graduate School of Frontier Sciences The University of Tokyo Tokyo Japan.
Motoko MizukamiDepartment of Laboratory Medicine The Institute of Medical Science, The University of Tokyo Tokyo Japan.
Kazuaki YokoyamaDepartment of Hematology/Oncology Research Hospital, The Institute of Medical Science, The University of Tokyo Tokyo Japan.
Aki SatoDepartment of Hematology/Oncology Research Hospital, The Institute of Medical Science, The University of Tokyo Tokyo Japan.
Tokiko Nagamura-InoueDepartment of Cell Processing and Transfusion Institute of Medical Science, The University of Tokyo Tokyo Japan.
Yasuhito NannyaDepartment of Hematology/Oncology Research Hospital, The Institute of Medical Science, The University of Tokyo Tokyo Japan.
Kaoru UchimaruDepartment of Computational Biology and Medical Sciences Laboratory of Tumor Cell Biology, Graduate School of Frontier Sciences The University of Tokyo Tokyo Japan.
Tokyo Medical University Hospital · JPThe University of Tokyo · JPTokyo Medical University · JPChiba University · JP
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Progression of adult T-cell leukemia/lymphoma from smoldering to acute type due to branched subclonal evolution. · full record | OpenQuestion